2 material Form 8-K filings that 2 companies we cover made with the SEC in March 2012, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
H&Q Life Sciences Investors said its Board of Trustees authorized a renewal of the Fund's share repurchase program. The renewed program would let the Fund buy up to 12% of its outstanding common shares in the open market for one year, starting July 11, 2012, after the current program ends on July 10, 2012. The Board said the aim is to increase net asset value per share and possibly narrow the discount between market price and net asset value.
Renewed program allows open-market purchases of up to 12% of outstanding common shares
Current program runs through July 10, 2012; renewal covers the one-year period beginning July 11, 2012
Repurchase amount and timing are at the discretion of Hambrecht & Quist Capital Management LLC, the Fund's adviser
The filing states there is no assurance shares will be bought at any specific discount or amount, or that market price will rise
The Board of Trustees authorized a renewal of the fund's share repurchase program, which allows open-market purchases of up to 12% of outstanding common shares for one year starting July 11, 2012. The board says the program aims to raise net asset value per share and narrow the gap between the share price and net asset value.
Renewed program allows open-market purchases of up to 12% of outstanding common shares
Current program runs through July 10, 2012; renewal covers the one-year period beginning July 11, 2012
Amount and timing of repurchases are at the discretion of investment adviser Hambrecht & Quist Capital Management LLC
Filing states there is no assurance of purchases at any specific discount level, amount or date
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.